Showing results (461-470 of 475) with videos related to
Sort By:
Pageof 48
Ebiomedicine|November 9, 2024
Genomic insights for personalised care in lung cancer and smoking cessation: motivating at-risk individuals toward evidence-based health practicesTony Chen, Giang Pham, Louis Fox, et al.The Journal of Pathology|May 16, 2007
Molecular classification and genetic pathways in hyperplastic polyposis syndromeL G Carvajal-Carmona, K M Howarth, M Lockett, et al.The New England Journal of Medicine|June 30, 2000
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposisG Steinbach, P M Lynch, R K Phillips, et al.World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 12, 2021
An organization- and category-level comparison of diagnostic requirements for mental disorders in ICD-11 and DSM-5Michael B First, Wolfgang Gaebel, Mario Maj, et al.Journal of Behavioral Addictions|August 18, 2017
Gaming disorder: Its delineation as an important condition for diagnosis, management, and preventionJohn B Saunders, Wei Hao, Jiang Long, et al.Comprehensive Psychiatry|May 19, 2020
Preventing problematic internet use during the COVID-19 pandemic: Consensus guidanceOrsolya Király, Marc N Potenza, Dan J Stein, et al.Journal of Veterinary Internal Medicine|March 23, 2020
Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC studyAdrian Boswood, Sonya G Gordon, Jens Häggström, et al.Addiction (Abingdon, England)|January 15, 2021
Expert appraisal of criteria for assessing gaming disorder: an international Delphi studyJesús Castro-Calvo, Daniel L King, Dan J Stein, et al.Journal of Veterinary Internal Medicine|December 8, 2017
Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC StudyA Boswood, S G Gordon, J Häggström, et al.Journal of Veterinary Internal Medicine|September 29, 2016
Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical TrialA Boswood, J Häggström, S G Gordon, et al.Pageof 48